Uterine Cancer Plasma
About: Uterine Cancer Plasma – Cryopreserved human plasma collected from clinically confirmed uterine cancer donors. Uterine cancer plasma is ideal for biomarker discovery and developing new treatment strategies.
Uterine Cancer Plasma | High-Quality Human Plasma from Uterine Cancer Donors
Uterine Cancer Human Plasma is collected from donors clinically diagnosed with uterine cancer and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human uterine cancer plasma supports research focused on biomarker discovery and monitoring, inflammation profiling, and therapeutic development for uterine cancer.
Product Features
- Research Use Only (RUO)
- Uterine cancer human plasma collected from clinically confirmed donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified uterine cancer diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional uterine cancer-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Uterine cancer plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – Bulk plasma is available: https://sanguinebio.com/product/human-bulk-plasma/
1 Answer
YES – The “Specify I/E Criteria” service allows you to define specific inclusion/exclusion criteria including lifestyle restrictions.
1 Answer
YES – Sanguine offers longitudinal collections.
1 Answer
YES – Sanguine offers matched samples across multiple matrices and age-matched controls.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.